PBC Biomed announces opening of Memphis office

PBC BioMed, a medical device design and development company headquartered in Shannon, Ireland, today announced that it will open first U.S. office in Memphis, TN.

The PBC BioMed Leadership team, Gerard Insley, Chief Science Officer, Dr. Thomas Russell, Chief Medical Officer, and Brittney Martinez, VP of Business Development and Marketing, were on-site this week for the official office opening at Epicenter, located at 150 Peabody Place. They were joined by Memphis Chamber President and CEO, Ted Townsend, and Jessica Taveau, the CEO of Epicenter.  

PBC BioMed has an established track record of innovation since they first opened in Shannon in 2010. With a deep understanding of the regulatory, quality, clinical and commercial requirements facing innovators in Europe and the U.S., the PBC BioMed team are dedicated to accelerating medical innovation within the area of Biomaterials, through partnerships with healthcare professionals, academic institutions, and Medtech companies. Tennessee is an ideal first location for PBC BioMed in the U.S., as it is the second highest exporter of medical equipment, with Memphis specifically being home to a multitude of medical device companies.

Memphis Chamber President and CEO, Ted Townsend was on site this week to welcome the PBC BioMed team and enthused,”Thanks to our central location, logistics prowess, and diverse workforce, Memphis has long been at the heart of medical technology innovation that is saving and improving lives across the world. Memphis is a natural fit for the first U.S. office of PBC BioMed, who are helping medical device companies develop their life-saving and life-changing products. This foreign direct investment in Memphis is also an investment in the future growth of our Medtech companies and startups.”

Paul Burke, Managing Partner for PBC BioMed, said, ”PBC Biomed has a long legacy of collaboration in the U.S. and Memphis area, stretching back over 10 years. The office in Memphis is an inevitable expansion of our U.S. operations and we are excited to bring our innovation experience and unique skillset to the area, to collaborate with local innovators, academia and industry partners.”

PBC BioMed’s Chief Medical Officer, Dr Toney Russell, commented: “It is exciting to welcome PBC BioMed to the Memphis area. This has been my home for almost 50 years and where I received my medical education and entry into the Medical Device Industry.  Numerous innovations and advancements in healthcare that have originated in this area, have healed many of the worlds’ sick and injured. We hope to contribute to this legacy with our world-wide team of physicians, scientists, academicians, engineers and specialists in medical commercialization, working in partnership with those with a passion for improving healthcare.”

For more information on PBC BioMed or to submit a request for support, please visit the website at https://www.pbcBioMed.com/aim/ or reach out to a member of the team at info@pbcBioMed.ie.

About PBC BioMed Ltd – Accelerating Medical Innovation

PBC BioMed was founded in 2010, with the mission of being the preferred partner for accelerating medical innovations from concept to commercialisation, to make a meaningful difference in patients’ lives. PBC BioMed delivers value to small, medium, and large MedTech ventures, through a wide array of services that include R&D, quality, regulatory, contract manufacturing, supply chain and commercialisation. With 3 global locations, PBC BioMed is the strategic partner for medical innovation from ideation to implantation.